Press release
Key Influencer in the Epigenetics Drugs And Diagnostic Technologies Market 2025: Rising Cancer Rates Drive Demand For Advanced Epigenetic Solutions Driver
There has been a rapid expansion in the market size of epigenetics drugs and diagnostic technologies in recent years, with projections suggesting growth from $15.49 billion in 2024 to $18.86 billion in 2025, at a compound annual growth rate (CAGR) of 21.8%. Factors contributing to the historical market growth include improved comprehension of epigenetic mechanisms, advancement in genome-wide association studies (GWAS), surging demand for healthcare, rise in the elderly population, and an increased prevalence of cancer.
The market size of epigenetics drugs and diagnostic technologies is forecasted to witness significant growth over the next few years, expanding to $41.03 billion in 2029 with a compound annual growth rate (CAGR) of 21.4%. The forecasted growth is driven by factors such as the rising instances of neurological diseases, increased cases of inflammatory disorders, escalating prevalence of chronic diseases, burgeoning demand for tailored medicine, and higher awareness and use of epigenetic diagnostics. Expected trends during the forecast period include revolutionary developments in personalized therapies based on epigenetics, the confluence of epigenomics and artificial intelligence, advancements in multi-omics research methods and clinical practice, state-of-the-art technologies and pioneering techniques in diagnosis.
What Factors Are Propelling the Expansion of the Epigenetics Drugs And Diagnostic Technologies Market?
The rise in cancer cases is anticipated to fuel the expansion of the market for epigenetics drugs and diagnostic technologies. Cancer is a group of diseases characterized by uncontrolled cellular growth which can metastasize to other body parts. The growing incidence of cancer is linked to elements such as aging populations, alterations in lifestyle, environmental contamination, genetic tendencies, and enhanced diagnostic methods. Epigenetic medicines and diagnostic technologies contribute to cancer prevention by targeting and altering gene expression, thus allowing for early identification and tailored treatment approaches. For example, the Australian Institute of Health and Welfare, a government agency in Australia, reported in July 2024 that the count of diagnosed cancer cases in Australia rose from 156,781 in 2021 to 160,570 in 2022. As a result, the escalating prevalence of cancer is driving the growth of the market for epigenetics drugs and diagnostic technologies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19418&type=smp
Which Businesses Are at the Forefront of Epigenetics Drugs And Diagnostic Technologies Market Development?
Major companies operating in the epigenetics drugs and diagnostic technologies market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Illumina Inc., QIAGEN NV, Exact Sciences Corporation, Abcam PLC, Syndax Pharmaceuticals Inc., Astex Pharmaceuticals Inc., Diagenode LLC, Cisbio Bioassays, 4SC AG, Verogen Inc., Watchmaker Genomics Inc., Oryzon Genomics SA, Cell Centric Ltd., Epiaxis Therapeutics
What Are the Latest Innovations in the Epigenetics Drugs And Diagnostic Technologies Market?
Leading businesses in the epigenetics drugs and diagnostic technologies market are concentrating on the creation of innovative technologies like DNA methylation analysis technology. This technology enhances the accuracy and efficacy of disease detection, enriches personalized treatment plans, and progresses our comprehension of gene regulation in multiple diseases. DNA methylation analysis technology is a collection of methods used to examine DNA methylation patterns, a chemical alteration of DNA that entails the addition of a methyl group to the DNA's cytosine base. For example, Watchmaker Genomics Inc., a biotechnology firm based in the US, teamed up with Exact Sciences Corp., a US-based molecular diagnostics firm, in August 2023. Together, they aim to develop and market a new DNA methylation analysis technology branded TET-assisted pyridine borane sequencing (TAPS). This collaboration seeks to augment cancer screening and diagnostic capabilities, utilizing Watchmaker's proficiency in engineering DNA-modifying enzymes to refine TAPS chemistry. This initiative is critical for early cancer detection and monitoring minimal residual disease (MRD) via liquid biopsies, with DNA methylation patterns serving as health status biomarkers.
How Is the Epigenetics Drugs And Diagnostic Technologies Market Segmented?
The epigenetics drugs and diagnostic technologiesmarket covered in this report is segmented -
1) By Technology: Deoxyribonucleic Acid (DNA) Methylation, Histone Methylation, Histone Acetylation, Large Non Coding Ribonucleic Acid (RNA), MicroRNA Modification, Chromatin Structures
2) By Application: Oncology, Solid Tumors, Liquid Tumors, Non Oncology, Inflammatory Diseases, Metabolic Diseases, Infectious Diseases, Cardiovascular Diseases, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Deoxyribonucleic Acid (DNA) Methylation: Methylation Inhibitors, Methylation Detection Kits, Methylation Profiling Technologies, Bisulfite Sequencing
2) By Histone Methylation: Histone Methyltransferase Inhibitors, Histone Demethylase Inhibitors, Histone Methylation Assays, Chromatin Immunoprecipitation (ChIP) Techniques
3) By Histone Acetylation: Histone Acetyltransferase Inhibitors, Histone Deacetylase Inhibitors (HDACi), Acetylation Detection Kits, Western Blotting for Acetylation
4) By Large Non-Coding Ribonucleic Acid (RNA): lncRNA Expression Profiling, lncRNA Modulation Technologies, lncRNA Detection Kits, Bioinformatics Tools for lncRNA Analysis
5) By MicroRNA Modification: MicroRNA Mimics, MicroRNA Inhibitors, MicroRNA Expression Analysis, MicroRNA Detection Assays
6) By Chromatin Structures: Chromatin Remodeling Agents, Chromatin Accessibility Assays, 3D Chromatin Architecture Technologies, Nuclear Imaging Techniques
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/epigenetics-drugs-and-diagnostic-technologies-global-market-report
Where Is the Epigenetics Drugs And Diagnostic Technologies Market Growth Most Prominent?
North America was the largest region in the epigenetics drugs and diagnostic technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epigenetics drugs and diagnostic technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Epigenetics Drugs And Diagnostic Technologies Global Market Report?
- Market Size Analysis: Analyze the Epigenetics Drugs And Diagnostic Technologies Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Epigenetics Drugs And Diagnostic Technologies Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Epigenetics Drugs And Diagnostic Technologies Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Epigenetics Drugs And Diagnostic Technologies Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19418"
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Epigenetics Drugs And Diagnostic Technologies Market 2025: Rising Cancer Rates Drive Demand For Advanced Epigenetic Solutions Driver here
News-ID: 3873934 • Views: …
More Releases from The Business Research Company
Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, A …
The High-Resolution Anoscopy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the High-Resolution Anoscopy Market Size and Projected Growth Rate?
The market size for high-resolution anoscopy has experienced significant growth over the past few years. The market is predicted to increase from $15.03 billion…
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 203 …
"The Condyloma Acuminata Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Condyloma Acuminata Treatment Market Size During the Forecast Period?
In the past few years, the condyloma acuminata treatment market has seen significant growth. The market value, which is anticipated to…
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"The Household Type Fans Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Household Type Fans Market?
The market size for household fans has seen consistent expansion in recent years. The projections indicate an increase from $32.22 billion in 2024…
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecast …
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Grain Fumigants Market Size During the Forecast Period?
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
More Releases for Diagnostic
Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804
This latest report researches the industry structure, sales, revenue,…
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688
This latest report researches the industry structure, sales, revenue,…
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of…
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…
